The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Stock picking tips

Fri, 06th Mar 2020 15:39

* Bourses fall in virus worries
* Europe's bank at lowest since 2009

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Thyagaraju Adinarayan
(thyagaraju.adinarayan@tr.com), Joice Alves (joice.alves@tr.com), Julien Ponthus
(julien.ponthus@tr.com) in London.

STOCK PICKING TIPS (1540 GMT)
Here are some stock picking tip from BNP Paribas' Edmund Shing.
"You will find that stocks that are sensitive to bonds, relatively speaking are caught up
better than the market overall. Now the stocks that tend to be more bond sensitive are
defensive, and tend to be located in sectors like healthcare and utilities for instance," he
told us in an interview.
"That is often because they have lots of debt," he adds.
Shing also gives hints on how to pick the best stocks in the coronavirus era, beyond the big
utilities names.
"It's very difficult: One strategy you can employ is looking for companies that are falling
off," he says, if you don't find an explanation - like a profit warning or something
fundamentally wrong - this company may be your pick.
Smaller companies often suffer when there is a big sell-off, because in panic selling
investors rush to take some profits off the table, but "in fact the companies that suffer the
sharpest fall sometimes can be those which have very strong fundamentals, which explain why they
had such good performance before the crisis".
"When fundamentals and valuations are diverging, there is a chance that at some point the
price will shoot up, and prices at some point rejoins fundamentals".
(Joice Alves)
*****


WHAT A RIDE FOR UTILITIES! (1411 GMT)
The sector is losing some ground today, although it's still outperforming the others in the
daily coronavirus sell-off we've been seeing of late in Europe. Year-to-date it has been
a darling among investors surviving the meltdown in markets.


European utilities have delivered a double-digit return so far this year and there is more
to that than the bond yield, DB's James Brand writes. Here is his guess why:
- The turn in earnings cycle and return to growth
- Enthusiasm for ESG
- The coronavirus driven rotation into defensives
"Interestingly our correlation analysis suggests that this could be justified just by the
drop in bond yields. However, our view is that robust medium-term earnings growth and long-term
investment opportunities related to ESG may be better reasons to remain bullish," Brand adds.

(Joice Alves)
*****


CARNAGE! (1323 GMT)
Are markets losing it? Bear market territory is not too far away for many bourses. The
pan-European STOXX 600 index has now fallen close to 16% from record highs. Wall Street
meanwhile is getting ready for a 3.2% drop.
"We think that equities will need more visibility if they are to manage to build a viable
bottom or to be able to tap into the power afforded by a reasonable sense of relief – for
example, as a result of easing in the momentum of new coronavirus cases also outside China,"
Christian Stocker at UniCredit says.




(Thyagaraju Adinarayan)
*****

EUROPE'S BANKS AT LOWEST SINCE 2009 (1110 GMT)
European banks are down close to 4% and have now hit their lowest since 2009 as the
coronavirus scare cuts deeper into global markets.
We're past bear territory with a fall of about 25% since February.
Seems there's a combination of straight recession fears (with all that means in terms of
toxic NPLs quickly building up) and expectations of another ECB cut which would bite hard into
margins again.
Germany's 10-y govt bond yield fell to -0.740%, which is very, very close to its record low
of -0.743 of September 2019.
"The situation of the European banking sector is completely different from what it was in
2009", Jerome Legras, head of research at Axiom Alternative Investments just told us.
"There’s the psychological aspect of hitting the same level but I’m not more worried about
their solvency than I was three weeks ago", he added.
"Profitability is a different story though..."

Take a look:


(Joice Alves and Julien Ponthus)
*****



OPENING SNAPSHOT: NOT THE TIME FOR TRAVEL & LEISURE (0823 GMT)
European bourses open in negative territory as coronavirus fears continue to drag down the
stock market.
The pan European index is on track for its third straight day of declines and
needless to say the travel and leisure space is lagging behind all the other sectors,
down more than 3%.
In terms of single stocks, Italy's Prysmian started the day among the top movers,
down almost 10%, after it warned that core profit will not grow this year, blaming trade
tensions, higher tariffs and the coronavirus outbreak.
Capita's capitulation continues as brokers cut price targets after the company's
update yesterday sent shares down 40%.

(Joice Alves)
*****


STOCKS TO WATCH: INFINEON, AIRBUS, ESSILORLUXOTTICA (0745 GMT)
Futures point to another blow for European bourses with 2% plus declines across the board as
coronavirus anxiety continues to grip investors.
In the corporate world, Infineon in focus after a Bloomberg reported that
Washington recommended Trump to block the German chipmaker's proposed $10 billion deal to buy
Cypress Semiconductor as it poses a security risk.
Airbus shares could take a hit as it got zero orders for February due to
coronavirus, but worth remembering that the recent sell-off has likely priced-in most of the bad
news.
EssilorLuxottica is the other name to watch out for after the company said it
expects is first-half revenues to be slower (I'd let you guess the why here).
Non-virus news: British pharma AstraZeneca seen down 2% after its combination
treatment for a form of bladder cancer failed to meet the main goal.

(Thyagaraju Adinarayan)
*****


ANOTHER DAY, ANOTHER SELL-OFF (0637 GMT)
Stocks are seen opening sharply lower again today on top of yesterday's ugly sell-off that
took bank stocks into bear market territory along with autos, travel & leisure and oil & gas.
The number of global coronavirus cases is fast approaching the 100k mark with fears of a
massive economic damage sending shivers down investors' spine.
Financial spreadbetters IG expect London's FTSE to open 114 points lower at 6,592,
Frankfurt's DAX to open 255 points lower at 11,690 and Paris' CAC to open 116 points lower at
5,246.
"Markets have shifted from pricing temporary China weakness to a more protracted global
event, which will see a good chunk of global GDP go up in smoke," said Stephen Innes, chief
market strategist at AxiCorp.

(Thyagaraju Adinarayan)
*****





(Reporting by Joice Alves, Julien Ponthus and Thyagaraju Adinarayan)

More News
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more
27 Dec 2023 17:04

Rate-cut optimism, autos push UK stocks higher

FTSE 100 up 0.4%, FTSE 250 adds 0.5%

*

Read more
27 Dec 2023 17:02

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

Read more
27 Dec 2023 14:25

London close: Stocks maintain gains amid post-Christmas rally

(Sharecast News) - London's stock markets closed in positive territory on Wednesday, buoyed by a global surge in stock prices as the S&P 500 neared an all-time high on Wall Street.

Read more
27 Dec 2023 12:06

LONDON MARKET MIDDAY: Stocks hold onto gains amid US rate cut hopes

(Alliance News) - London's FTSE 100 index was outperforming other European stock-price measures at midday on Wednesday, boosted by gains for miners and industrials.

Read more
27 Dec 2023 11:20

London midday: Stocks ride global wave of post-Christmas optimism

(Sharecast News) - London's equity markets were still above the waterline at lunchtime on Wednesday, following a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.